Attorneys Christopher T. Sweeney and Daniel A. Kamkar authored “What pharma should know about the European Unitary Patent in light of Brexit” which was published in Pharmafile.
Read the full article on Pharmafile’s website >> (subscription required)
Attorneys Christopher T. Sweeney and Daniel A. Kamkar authored “What pharma should know about the European Unitary Patent in light of Brexit” which was published in Pharmafile.
Read the full article on Pharmafile’s website >> (subscription required)
Daniel A. Kamkar’s practice focuses on worldwide patent prosecution and portfolio management, patent infringement and validity analyses, freedom to operate analyses, USPTO proceedings, and general IP licensing. Daniel currently assists...